š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a 26 week randomized controlled study. The study consists of, in or...
Status
Completed
Location
VA WNY Healthcare System
Start Date
2010-09
Trial ID
NCT01186822
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
Phase II study to evaluate safety and efficacy of DCP-001 in patients with ...
Status
Unknown
Location
Helsinki University Hospital
Start Date
2018-10-15
Trial ID
NCT03697707
Treatments Being Tested
The purpose of this study is to compare the effects of two different anti-H...
Status
Completed
Location
UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS
Start Date
2002-01
Trial ID
NCT00385632
Treatments Being Tested
Comparison of the safety and effectiveness of standard drug dosing versus a...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00250432
Treatments Being Tested
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
This treatment protocol will enable therapeutic use of Anascorp in the mana...
Status
Completed
Location
Casa Grande Regional Medical Center
Start Date
2005-05
Trial ID
NCT00624078
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
This study is determining the maximum tolerated dose and safety of SU011248...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-07
Trial ID
NCT00712504
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947